Minimal Clinically Important Difference After Triamcinolone Acetonide Injection for Knee Osteoarthritis
This study establishes MCID values for KOOS subscales in patients with knee OA receiving TA injections using a distribution-based method, which are similar regardless of duration of follow-up within 6 months. Patients can expect significant pain improvement within the first month, with declining effects thereafter. Lack of early pain improvement correlates with a higher likelihood of repeat injection, supporting the need for follow-up assessments to guide ongoing treatment.
Authors
- Leslie J. Bisson (ORCID: https://orcid.org/0000-0003-2879-1310)
- Jesse M. Galina (ORCID: https://orcid.org/0000-0002-2703-7116)
- Meghan Morley (ORCID: https://orcid.org/0000-0003-1662-8356)
- Sibtain Mustafa
- Mohammad Nadir Haider
- Nomi S. Weiss-Laxer
- Sophia Bisson
Institutions
- Maimonides Medical Center (US)
- Jacobs Institute (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- Clinical Journal of Sport Medicine
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1097/jsm.0000000000001412
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00